SNTI — Senti Biosciences Holdings Share News
0.000.00%
Last trade - 00:00- $33.95m
- $25.01m
- $0.02m
Brief: Senti Biosciences - On Aug 7 Got Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Of Listing From Nasdaq
Senti Biosciences Inc expected to post a loss of 48 cents a share - Earnings Preview
Senti Biosciences Inc expected to post a loss of 48 cents a share - Earnings Preview
Senti Biosciences Inc reports results for the quarter ended in March - Earnings Summary
Brief: Senti Bio Announces First Quarter 2023 Results And Pipeline Updates
Brief: Senti Bio Posts Q4 Net Loss Of $18.2 Mln
Brief: Senti Bio Reports Q4 Results
U.S. STOCKS ON THE MOVE-Senti Biosciences, Autoliv, Nexstar Media
Senti to focus on lead blood cancer therapy development, shares rise
Brief: Senti Bio Announces Pipeline Prioritization, Updates Cash Runway Guidance
U.S. STOCKS ON THE MOVE-Natural gas, Box Inc, Weber
Senti up as pre-clinical data from lead cancer therapy shows promise
Brief: Senti Bio Says Highlights Preclinical Data From Logic-Gated Gene Circuit CAR-NK Cell Therapy SENTI-202
Brief: Senti Bio Reports Third Quarter Results
Brief: Senti Biosciences Inc Maintain Expectation Of Cash Runway Into 2024
Senti Biosciences jumps as BofA starts coverage with "buy"
Chardan Capital starts Senti Biosciences coverage with 'buy'
U.S. RESEARCH ROUNDUP-Costco Wholesale, Lendingclub, Senti Biosciences
Brief: Senti Biosciences Files For Offering Of Up To 8.73 Mln Shares Of Common Stock By Selling Securityholder